Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss attributable to Tecogen Inc. $ (1,079,205) $ (978,540)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 85,601 55,857
Recovery (provision) for losses on accounts receivable 50,600 (8,900)
Stock-based compensation 32,491 57,638
Changes in operating assets and liabilities    
Short-term investments 0 (202)
Accounts receivable (559,604) (306,849)
Inventory (129,464) (49,077)
Unbilled revenue (71,710) (354,625)
Due from related party (306,305) 55,837
Prepaid expenses and other current assets (135,875) 92,803
Increase (Decrease) in Other Operating Assets 32,000 0
Increase (decrease) in:    
Accounts payable (474,002) 310,898
Accrued expenses 267,898 198,618
Due to related party 452,490 (110,511)
Deferred revenue (119,667) 760,535
Interest payable, related party (198,450) 20,802
Net cash used in operating activities (2,153,202) (255,716)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (55,964) (313,002)
Purchases of intangible assets (36,422) (323,391)
Payments to Acquire Short-term Investments (583,720) 0
Net cash used in investing activities (676,106) (636,393)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments of Related Party Debt 2,950,000 0
Proceeds from Stock Options Exercised 6,300 0
Proceeds from sale of subsidiary common stock 6,000 0
Net cash provided by (used in) financing activities (2,937,700) 0
Net increase (decrease) in cash and cash equivalents (5,767,008) (892,109)
Cash and cash equivalents, beginning of the period 7,713,899  
Cash and cash equivalents, end of the period 1,946,891 680,676
Non-cash investing and financing activities:    
Interest paid $ 233,220 $ 0